- Home
- CTSO vs VIVK Comparison
CTSO vs VIVK Comparison
Compare CTSO & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- VIVK
- Stock Information
- Founded
- CTSO 1997
- VIVK 2006
- Country
- CTSO United States
- VIVK United States
- Employees
- CTSO N/A
- VIVK N/A
- Industry
- CTSO Medical/Dental Instruments
- VIVK Oilfield Services/Equipment
- Sector
- CTSO Health Care
- VIVK Energy
- Exchange
- CTSO Nasdaq
- VIVK Nasdaq
- Market Cap
- CTSO 52.6M
- VIVK 50.6M
- IPO Year
- CTSO N/A
- VIVK N/A
- Fundamental
- Price
- CTSO $1.18
- VIVK $0.97
- Analyst Decision
- CTSO Buy
- VIVK
- Analyst Count
- CTSO 2
- VIVK 0
- Target Price
- CTSO $5.50
- VIVK N/A
- AVG Volume (30 Days)
- CTSO 99.9K
- VIVK 2.0M
- Earning Date
- CTSO 08-12-2025
- VIVK 08-15-2025
- Dividend Yield
- CTSO N/A
- VIVK N/A
- EPS Growth
- CTSO N/A
- VIVK N/A
- EPS
- CTSO N/A
- VIVK N/A
- Revenue
- CTSO $35,332,238.00
- VIVK $111,130,140.00
- Revenue This Year
- CTSO $18.34
- VIVK N/A
- Revenue Next Year
- CTSO $19.82
- VIVK N/A
- P/E Ratio
- CTSO N/A
- VIVK N/A
- Revenue Growth
- CTSO 15.37
- VIVK 85.84
- 52 Week Low
- CTSO $0.70
- VIVK $0.55
- 52 Week High
- CTSO $1.61
- VIVK $3.45
- Technical
- Relative Strength Index (RSI)
- CTSO 67.21
- VIVK 58.48
- Support Level
- CTSO $1.03
- VIVK $0.73
- Resistance Level
- CTSO $1.29
- VIVK $1.01
- Average True Range (ATR)
- CTSO 0.09
- VIVK 0.14
- MACD
- CTSO 0.02
- VIVK 0.00
- Stochastic Oscillator
- CTSO 75.45
- VIVK 58.52
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.